Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (27)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Scharf, J. G.
Right arrow Articles by Hartmann, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Scharf, J. G.
Right arrow Articles by Hartmann, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 19, 2121-2128, Copyright © 1998 by Oxford University Press


ARTICLES

Characterization of the insulin-like growth factor axis in a human hepatoma cell line (PLC)

JG Scharf, W Schmidt-Sandte, SA Pahernik, G Ramadori, T Braulke and H Hartmann
Department of Medicine, George-August-Universitat, Gottingen, Germany. jscharf@med.uni-goettingen.de

The insulin-like growth factors (IGF-I and -II) are structurally related peptides participating in the regulation of metabolism, growth and cellular differentiation. In the present study, the human hepatoma cell line PLC was studied for the expression of individual components of the IGF axis. Northern blot analysis using IGF-I and -II coding cDNAs failed to detect IGF-I- or -II-specific transcripts in total RNA from PLC cells. Biosynthesis of type I and II IGF receptors was demonstrated by northern blotting and binding studies as well as cross- linking of the respective radiolabeled ligand. Both IGF-I and -II stimulated [3H]-thymidine incorporation dose-dependently. The mitogenic activity of exogenously added IGFs was reduced by the presence of IGF- binding proteins of 24, 30, 34, 41 and 45 kDa in supernatants of PLC cells identified as IGFBP-4, -1, -2 and -3, respectively, by [125I]IGF- I ligand-, immuno- and northern blotting. Biosynthesis of IGFBP-3 was stimulated dose-dependently by IGF-I and -II, while IGFBP-1, -2 and -4 were not affected. The increase of IGFBP-3 in response to IGF-I and -II was due to a stimulation of IGFBP-3 specific mRNA as well as to an inhibition of IGFBP-3 endocytosis. Proteolytic activity for rhIGFBP-3 was detected in media from PLC cells at acidic pH that was inhibited by the aspartyl protease inhibitor pepstatin A as well as after immunodepletion of cathepsin D from media of PLC cells. Thus, a role of cathepsin D for the regulation of IGFBP-3 bioavailability via endocytosis in acidic prelysosomal compartments was suggested. The susceptibility of PLC for IGF-I and -II was restricted by their ability to increase the abundance of inhibitory IGFBPs and to decrease the level of IGF-I receptor expression. The present data point to the IGF axis as a complex regulatory system that self limits the mitogenic activity of exogenous IGFs.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
CarcinogenesisHome page
W. Cheng, C.-J. Tseng, T. T.C. Lin, I. Cheng, H.-W. Pan, H.-C. Hsu, and Y.-M. Lee
Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway
Carcinogenesis, July 1, 2008; 29(7): 1319 - 1326.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Y. Lee, C. Y. Han, J. W. Yang, C. Smith, S. K. Kim, E. Y.-H. P. Lee, S. G. Kim, and K. W. Kang
Induction of Glutathione Transferase in Insulin-Like Growth Factor Type I Receptor-Overexpressed Hepatoma Cells
Mol. Pharmacol., October 1, 2007; 72(4): 1082 - 1093.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J.-G. Scharf, F. Dombrowski, R. Novosyadlyy, C. Eisenbach, I. Demori, B. Kubler, and T. Braulke
Insulin-Like Growth Factor (IGF)-Binding Protein-1 Is Highly Induced during Acute Carbon Tetrachloride Liver Injury and Potentiates the IGF-I-Stimulated Activation of Rat Hepatic Stellate Cells
Endocrinology, July 1, 2004; 145(7): 3463 - 3472.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
H. Huynh, P. K. H. Chow, L. L. P. Ooi, and K.-C. Soo
A Possible Role for Insulin-like Growth Factor-binding Protein-3 Autocrine/Paracrine Loops in Controlling Hepatocellular Carcinoma Cell Proliferation
Cell Growth Differ., March 1, 2002; 13(3): 115 - 122.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Shalamanova, B. Kubler, J.-G. Scharf, and T. Braulke
MDCK cells secrete neutral proteases cleaving insulin-like growth factor-binding protein-2 to -6
Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1221 - E1229.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
J-G Scharf, F Dombrowski, and G Ramadori
The IGF axis and hepatocarcinogenesis
Mol. Pathol., June 1, 2001; 54(3): 138 - 144.
[Abstract] [Full Text]


Home page
GutHome page
R Issa, E Williams, N Trim, T Kendall, M J P Arthur, J Reichen, R C Benyon, and J P Iredale
Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors
Gut, April 1, 2001; 48(4): 548 - 557.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
H. M. Khandwala, I. E. McCutcheon, A. Flyvbjerg, and K. E. Friend
The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth
Endocr. Rev., June 1, 2000; 21(3): 215 - 244.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.